Skip to Main Content

Hello, everyone, and how are you this morning? We are just fine, thank you, now that the Pharmalot campus has settled down. The shortest of the short people has left for the local schoolhouse, and the official mascots are happily snoozing on the official Pharmalot office furniture. As for us, we are busy with our usual hunting and gathering. Toward that end, here are some tidbits. Hope you have a lovely day and remember us by sending juicy tips …

Three Valeant Pharmaceuticals execs are leaving, including former chief financial officer Rob Rosiello, who stepped down in August but stayed for a transition. Also leaving is Anne Whitaker and Ari Kellen, both executive vice presidents and company group chairmen. At the same time, Valeant named William Humphries, who formerly headed Merz North America, as executive vice president of dermatology.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!